Mass High Tech
ENERGESIS PHARMACEUTICALS
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
Pharmaceutical company focused on the discovery and development of drugs to treat Obesity, diabetes and associated metabolic diseases.
Headlines from Mass High Tech about ENERGESIS PHARMACEUTICALS
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2009 |
| Ownership Type | Private |
| Venture Funding | Subscriber access only |
| No. of Employees at this location | Subscriber access only |
| Total Number Employees | Subscriber access only |
| Anticipated Workforce Changes | Subscriber access only |
| Annual Sales | Subscriber access only |
| Foreign Distribution | Subscriber access only |
Contacts
| Olivier Boss | Founder/CSO | email available to subscribers | ||
| Brian Freeman | COO/Founder | |||
| Jean-Paul Giacobino | Founder | |||
| Scott Gullicksen | Sr Scientist |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Size | Subscriber access only |
| Website | http://www.energesispharma.com |
| Revenue | Subscriber access only |
Contact Information
| Address |
1 Cambridge Center 6th floor Cambridge, MA, 02142 |
| Phone | |
| Subscriber access only | |
| Website | www.energesispharma.com |
New England Tech Directory
| Browse
| Subscribe
| Advertise
| Networking
| About Us
| Search
| 
RSS Feeds
| 
| Directory License
| Update User Info
| Directory Privacy Policy
| Logout
© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.